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Nutritional and genetic factors alter the intestinal microflora, predisposing individuals toward metabolic
syndrome. Gewirtz and coworkers (Vijay-Kumar et al., 2010), employing Toll-like receptor 5 null mice, present
evidence for a direct relationship between malfunction of the innate immune system, changes in gut micro-
biota composition, and development of metabolic syndrome.The intestinal microbiota represents a
community of trillions of bacteria dwelling
in our intestine, with an aggregate bacte-
rial genome (microbiome) outweighing
by far our own human genome (Xu and
Gordon, 2003). Past evidence on the
role of the microbiota in human disease
focused largely on inflammatory bowel
disease and liver cirrhosis. Recent dis-
coveries of a heretofore unrecognized
role of the intestinal microflora offer new
hints for a deeper understanding on the
hidden origins of the metabolic syndrome.
The metabolic syndrome represents more
than a simple cluster of clinical conditions
associated with increased cardiovascular
risk. Glucose intolerance, dyslipidemia,Figure 1. Proposed Pathophysiological Events Linking Gut
Microbiota and the Development of Metabolic Syndrome
Recent evidence suggests that the microbiota may lead to the instau-
ration of metabolic impairment by a dual mechanism involving the
pathophysiological hallmarks of metabolic syndrome, namely insulin
resistance and low-grade chronic inflammation. On one hand, the
microbiota provides unique enzymes for the degradation of ingested
food, thereby promoting the absorption of nutrients, mainly carbohy-
drates; the increased influx of carbohydrates from the gut to the liver
results in increased lipogenesis that leads to insulin resistance, and
it is turbo-boosted by hyperinsulinemia. On the other hand, the anti-
genic stimulus of the gut microbiota directly sustains a condition of
systemic low-grade chronic inflammation. Although less well eluci-
dated, metabolic impairment shapes the gut microbiota, probably on
the basis of selection of bacteria species as dictated by the quantity
and quality of ingested nutrients.hypertension, and visceral obe-
sity are entwined by common
and mutually dependent path-
ophysiological events, namely
insulin resistance and low-grade
chronic systemic inflammation,
which uphold metabolic impair-
ment and lead to the develop-
ment of diabetes and atheroscle-
rosis (Eckel et al., 2005). Exciting
discoveries in the last few years
support a role for gut microbiota
as responsible for, and involved
in, the perpetuationof both insulin
resistance and low-grade chronic
inflammation (Figure 1). Very
recently, Gewirtz and coworkers
(Vijay-Kumar et al., 2010), using
transgenic mice, provided evi-
dence of the direct relationship
between development of the
metabolic syndrome, malfunc-
tion of the innate immune system,
and changes in the composition
of the gut microbiota.
A few years ago, the horizon of
the gut microbiota was extendedto the direct embracement of obesity and
metabolic impairment. In a seminal article
unveiling the essential role of microbiota
in promoting nutrient absorption and
weight gain in rodents, Ba¨ckhed et al.
showed that germ-free mice are leaner
than those harboring microbiota (Ba¨ckhed
et al., 2004). Of note, restoring the bacte-
rial content in adult germ-free mice rapidly
rescued the lean phenotype, resulting in
weight gain and insulin resistance. Many
of the bacterial genes are crucial for
proper degradation and absorption of
nutrients, as those responsible for carbo-
hydrate hydrolysis; increased processing
of ingested carbohydrates fostered mono-
saccharide uptake from the gut and wasCell Metabolisresponsible for increased lipogenesis in
the liver (Ba¨ckhed et al., 2004). Having
established the effects of the microbiota
on nutrient absorption and metabolic
regulation, the next step was to assess
whether the opposite held true. Both
animal and human studies confirmed
that obesity alters the intestinal microbial
ecology (Ley et al., 2005; Ley et al.,
2006; Turnbaugh et al., 2009). In partic-
ular, the characterization of the intestinal
flora in obese and lean twins led to the
discovery that, whereas covariation is
similar in monozygotic and dizygotic
twin pairs, obesity results in a significant
change in microbiota composition, both
in terms of bacterial phylum-level diversitym 11, Maand bacterial genes composition
(Turnbaugh et al., 2009). We also
know that the gut microbial
community is shaped by environ-
mental, nutritional, and genetic
factors (Hehemann et al., 2010;
Slack et al., 2009). Only a few
months ago, the employ of differ-
ent genetically modified mouse
models led to the identification
of the role of innate and adaptive
immune functions in determining
the composition of intestinal gut
microflora (Slack et al., 2009).
To close the circle, it remained to
show that genetic manipulations
of the immune system leading
to modifications in the gut micro-
biota would entrain metabolic
outcomes.
The issue was elegantly ad-
dressed last month in Science,
wherein Gewirtz and coworkers
unveiled the metabolic derange-
ment in Toll-like receptor 5
(TLR5) null mice (Vijay-Kumar
et al., 2010). Due to the absencey 5, 2010 ª2010 Elsevier Inc. 345
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Previewsof TLR5, which is a main component of
the innate immune system in the gut
mucosa, TLR5/ mice differ from
TLR5+/+ mice in the composition of bacte-
rial communities harboring the intestine.
Intriguingly, TLR5/ mice presented
increased adiposity, which was associ-
ated with clinical sequelae of metabolic
syndrome, i.e., elevated serum triglycer-
ides and cholesterol levels, increased
blood pressure, and insulin resistance.
Furthermore, feeding TLR5/ mice a
high-fat diet rapidly caused these mice
to become diabetic. Treating TLR5/
mice with broad spectrum antibiotics
decimated the gut microbiota and
rescued the metabolic phenotype, thus
causally linking these two events.
Conversely, transplantation of the gut
microbiota from TLR5/ mice to TLR5+/+
germ-free mice recapitulated the meta-
bolic phenotype. On a molecular level,
the phenotype observed in TLR5/
mice was linked to increased food intake
and absorption and induction of low-
grade inflammatory signaling, which
acted both in association and indepen-
dently. Therefore, the study of Gerwitz
and coworkers should be considered
a landmark for the direct genetic connec-
tion between microbiota, innate immune
system, and metabolic syndrome. Addi-
tional studies will show to what extent it
is possible to finely manipulate the com-
position of our intestinal flora in order to346 Cell Metabolism 11, May 5, 2010 ª2010ameliorate the metabolic profile. Also, it
will be crucial to determine whether
potential modification of the gut micro-
biota, leading to decreased food absorp-
tion and energy storage, is achievable
without compromising the assimilation
of vitamins and other fundamental nutri-
ents. Finally, the intriguing connection
between microbiota ecology and hyper-
phagia deserves a complete mechanistic
scenario. When these issues are solved,
the employ of anti-, pre-, or pro-biotics
in the arsenal of medications to treat
metabolic syndrome will definitively be
of enormous help.
The study of Gewirtz and coworkers
once more drives our attention to the
intestinal microflora as a causative agent
in the metabolic syndrome. While these
exciting discoveries reveal new hints on
the individual predisposition toward dis-
ease, the search for molecules that can
help us manage metabolic impairment
goes along with the need to admit that
fighting obesity and metabolic syndrome
will not be as easy as swallowing a pill.
We know that the genetic background
influences body weight as well as
response to dietary regimens and physical
exercise. Nevertheless, modification of
lifestyle habits remains the most important
strategy to fighting metabolic diseases,
both at individual and community levels
(Knowler et al., 2002). We now know that,
together with physical activity, it is imper-Elsevier Inc.ative to check the food that we eat and the
bacteria that it brings into our intestine.
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